Comparison

EDF vs Atopic Dermatitis

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

EDF

Features
Read full description

This guideline has been developed by and for doctors involved in the treatment of psoriasis. The recommendations for the different treatment options are rated according to their strength. The guideline offers advice on patient monitoring, contraindications and adverse events. Recommendations are also made for groups of patients who require special consideration when receiving psoriasis treatment, such as those with a history of malingnacy, HIV infection or impaired liver or kidney function. The guideline has originally been published in the Journal of the European Academy of Dermatology and Venereology (JEADV) by Nast A, et al. J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2277-94. doi: 10.1111/jdv.13354

About

Atopic Dermatitis

Features
Read full description

@Point of Care™ With Cognitive AI is a clinical decision-making mobile platform. Atopic Dermatitis @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. With Cognitive AI , clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI , confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Atopic Dermatitis @Point of Care™ is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated Atopic Dermatitis content • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients

Screenshots

EDF4 screens
Atopic Dermatitis4 screens

Verdict

The call

The clearest difference is update cadence: Atopic Dermatitis at every 5 weeks against EDF's every 7 months. EDF's advantage is iOS requirement (9.0 vs 14.0). On price, ads, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

EDF ships an update every 7 months, Atopic Dermatitis every 5 weeks. The most recent releases landed on October 1, 2026 and October 9, 2026 respectively.

Scorecard2 real differences · 4 level
EDF versus Atopic Dermatitis: the parameters behind the verdict, then further details
ParameterEDFAtopic Dermatitis
PriceFreeFree
Update frequencyEvery 7 monthsEvery 5 weeks — better
AdsNoNo
In-app purchasesNoNo
DevicesiPhone, iPodiPhone, iPad, iPod — better
Requires iOS9.0 — better14.0
Further details — not scored
Size2 MB23 MB
Age rating17+12+
Developerswiss4ward Europe S.L.@Point of Care

In-app purchases

None

EDF

No in-app purchases

None

Atopic Dermatitis

No in-app purchases

Questions

Is EDF free?
EDF is free to download, with no in-app purchases.
Is Atopic Dermatitis free?
Atopic Dermatitis is free to download, with no in-app purchases.
Do EDF or Atopic Dermatitis have ads?
Neither EDF nor Atopic Dermatitis shows ads.
Which is updated more often, EDF or Atopic Dermatitis?
EDF ships an update every 7 months, and Atopic Dermatitis every 5 weeks. Most recently, EDF was updated on October 1, 2026 and Atopic Dermatitis on October 9, 2026.

Other comparisons